Estimated risk of bleeding events in patients undergoing antithrombotic therapy (IMAGE)
Caption
Patients of antithrombotic therapy with reduced kidney function are at a higher risk of experience recurring bleeding events than patients with healthy kidney function. The blue and red lines represent the estimated risk of bleeding in high (greater than 50 mL/min) and low (less than 50 mL/min) estimated glomerular filtration rate (eGFR) groups respectively. The x-axis is the number of days since enrollment.
Credit
Kunihiko Matsui, MD, MPH of the Department of General Medicine and Primary Care, Kumamoto University Hospital, Kumamoto, Japan
Usage Restrictions
Credit must be given to the creator.
License
CC BY